Back to Clinical Research


Status: Not Enrolling Identifier: NCT02462889

Pro-Con: A Prospective, Single-blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) versus Sham as PROphylaxis against CONversion to Neovascular Age-related Macular Degeneration (AMD) in High-Risk Eyes

Condition: AMD

Study Type: Interventional

Duration: 24 months


  • Ages: Child, Adult, Senior
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information, please click here

Back to Clinical Research